Richard Bender, MD
Richard Bender received his MD degree from the UCLA School of Medicine followed by specialty training in Internal Medicine at UCLA-Harbor General Hospital. He then spent the next 6 years at the National Cancer Institute receiving his subspecialty training in hematology and medical oncology and as a senior investigator in the Medicine Branch doing laboratory and clinical research in such diverse areas as the therapy of ovarian cancer and malignant lymphoma, the membrane transport of antineoplastic drugs and the human pharmacology of vinca alkaloids. He then moved to Scripps Clinic and Research Foundation where he spent an additional 4 years dividing his time between laboratory research in folate transport and clinical practice.
Following a sojourn as a Senior Director in the oncology division of Johnson and Johnson, Dr. Bender became the medical director for hematology and oncology for Quest Diagnostics, a position he held for almost 6 years, before becoming the Chief Medical Officer and Senior VP for Spectrum Pharmaceuticals continuing his interest in oncology drug development. He continues to teach at the UC, Irvine School of Medicine and to co-edit Anti-Cancer Drugs, an international oncology journal, as well at to serve as an expert reviewer in oncology for the Medical Board of California.
Dr. Bender is the author of over 70 peer-reviewed scientific articles and numerous book chapters on topics including malignant lymphoma, pancreatic cancer and the clinical pharmacology of Vinca alkaloids